Multi-center phase 3 trial of minocycline HCl [hydrochloride] [minocycline] 1mg microspheres for the use in subjects with peri-implantitis.

Trial Profile

Multi-center phase 3 trial of minocycline HCl [hydrochloride] [minocycline] 1mg microspheres for the use in subjects with peri-implantitis.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Mar 2012

At a glance

  • Drugs Minocycline (Primary)
  • Indications Bacterial infections; Peri-implantitis
  • Focus Therapeutic Use
  • Sponsors Johnson & Johnson
  • Most Recent Events

    • 16 Mar 2012 Planned number of patients changed from 182 to 220 as reported by European Clinical Trials Database.
    • 07 Aug 2009 Actual patient number (50) added as reported by ClinicalTrials.gov.
    • 07 Aug 2009 Actual end date (1 Apr 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top